Cargando…

LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase

INTRODUCTION: LY3045697 is a potent and selective aldosterone synthase (CYP11B2) inhibitor that was developed as a safer alternative to mineralocorticoid receptor antagonists. Effects of LY3045697 on aldosterone and cortisol synthesis, as well as potassium ion homeostasis, were evaluated in two clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sloan-Lancaster, Joanne, Raddad, Eyas, Flynt, Amy, Jin, Yan, Voelker, James, Miller, Jeffrey W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843917/ https://www.ncbi.nlm.nih.gov/pubmed/28814143 http://dx.doi.org/10.1177/1470320317717883

Ejemplares similares

Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes
por: Sloan-Lancaster, Joanne, et al.
Publicado: (2013)

Pharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor
por: Raddad, E, et al.
Publicado: (2013)

Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587
por: Peng, Sheng-Bin, et al.
Publicado: (2017)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers
por: Monteith, David, et al.
Publicado: (2017)

Aldosterone synthase inhibitors in hypertension: current status and future possibilities
por: Hargovan, Milan, et al.
Publicado: (2014)

OR09-6 Selective and Durable Suppression of Aldosterone Production in Non-Human Primates by a Novel Aldosterone Synthase Inhibitor
por: Sparks, Steven, et al.
Publicado: (2019)

Population Pharmacokinetic and Pharmacodynamic Modeling of LY2510924 in Patients With Advanced Cancer
por: Bihorel, S, et al.
Publicado: (2017)

Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects
por: Freeman, Mason W., et al.
Publicado: (2023)

The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension
por: Forzano, Imma, et al.
Publicado: (2022)

Aldosterone Synthase Inhibitors and Dietary Interventions: A Combined Novel Approach for Prevention and Treatment of Cardiovascular Disease
por: Awosika, Ayoola, et al.
Publicado: (2023)

Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin II
por: Takeda, Yoshimichi, et al.
Publicado: (2018)

SUN-043 Epigenetic Regulation of Aldosterone Synthase Gene by Potassium
por: Takeda, Yoshiyu, et al.
Publicado: (2019)

High glucose stimulates expression of aldosterone synthase (CYP11B2) and secretion of aldosterone in human adrenal cells
por: Shimada, Hiroki, et al.
Publicado: (2017)

Radiosensitization by the Selective Pan-FGFR Inhibitor LY2874455
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2022)

Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice
por: Gu, Huiying, et al.
Publicado: (2017)

Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
por: Atkinson, Jennifer M., et al.
Publicado: (2015)

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome
por: Luo, Linlin, et al.
Publicado: (2016)

Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers
por: Freeman, Mason W., et al.
Publicado: (2022)

Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro
por: Vecchiola, Andrea, et al.
Publicado: (2013)

Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2)
por: Bogman, Katrijn, et al.
Publicado: (2017)

Developmental and communicative interrelations of Ly123 and Ly1 cell sets
Publicado: (1980)

LBODP025 A Novel Drug Discovery For Primary Aldosteronism Targeting Aldosterone Synthase (cyp11b2) And Kcnj5 Mutant
por: Otsubo, Yuri, et al.
Publicado: (2022)

Neces-SARI-ly?
por: Martin-Loeches, Ignacio, et al.
Publicado: (2016)

Urotensin II Exerts Pressor Effects By Stimulating Renin And Aldosterone Synthase Gene Expression
por: Caroccia, Brasilina, et al.
Publicado: (2017)

Author Correction: Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice
por: Gu, Huiying, et al.
Publicado: (2018)

Structural and functional insights into aldosterone synthase interaction with its redox partner protein adrenodoxin
por: Brixius-Anderko, Simoné, et al.
Publicado: (2021)

Discovery of Potential Inhibitors of Aldosterone Synthase from Chinese Herbs Using Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Studies
por: Luo, Ganggang, et al.
Publicado: (2016)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy
por: Schumacher, Christoph D., et al.
Publicado: (2013)

Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells
por: Alesutan, Ioana, et al.
Publicado: (2017)

Emerging Potential of Microwave Ablation for Primary Aldosteronism Resulting From Unilateral Aldosterone-producing Adenoma
por: Mills, Edouard G, et al.
Publicado: (2023)

Association of Aldosterone Synthase Polymorphism (CYP11B2 -344T>C) and Genetic Ancestry with Atrial Fibrillation and Serum Aldosterone in African Americans with Heart Failure
por: Bress, Adam, et al.
Publicado: (2013)

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
por: Reynolds, Harmony R., et al.
Publicado: (2020)

Running Mad-ly into mitosis
por: LeBrasseur, Nicole
Publicado: (2004)

Virulence profile: Hinh Ly
por: Ly, Hinh
Publicado: (2016)

Comparison of Mouse Ly5(a) and Ly5(b) Leucocyte Common Antigen Alleles
por: Zebedee, Suzanne L., et al.
Publicado: (1991)

Secretion of Ia antigens by a subpopulation of T cells which are Ly-1+, Ly-2-, and Ia-
Publicado: (1976)

Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism
por: Wu, Che-Hsiung, et al.
Publicado: (2013)

Aldosterone antagonism in heart failure
por: Miller, Alan B
Publicado: (2007)

Donanemab (LY3002813) dose‐escalation study in Alzheimer's disease
por: Lowe, Stephen Loucian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uni0hgfa8rp4rhh0htamnoo1sn